Archford Capital Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Buy
40,636
+13,660
+51% +$3.18M 1.05% 22
2026
Q1
$6.59M Buy
26,976
+1,953
+8% +$455K 0.76% 41
2025
Q4
$5.18M Buy
25,023
+11,548
+86% +$2.28M 0.6% 42
2025
Q3
$2.5M Buy
13,475
+4,331
+47% +$742K 0.3% 76
2025
Q2
$1.4M Sell
9,144
-27
-0.3% -$4.15K 0.18% 116
2025
Q1
$1.52M Sell
9,171
-19
-0.2% -$2.97K 0.22% 112
2024
Q4
$1.33M Buy
9,190
+54
+0.6% +$8.37K 0.2% 116
2024
Q3
$1.48M Sell
9,136
-400
-4% -$63.7K 0.22% 104
2024
Q2
$1.39M Sell
9,536
-3,511
-27% -$522K 0.23% 104
2024
Q1
$2.06M Sell
13,047
-535
-4% -$85.2K 0.35% 77
2023
Q4
$2.13M Sell
13,582
-670
-5% -$103K 0.39% 66
2023
Q3
$2.22M Buy
14,252
+1,195
+9% +$197K 0.44% 58
2023
Q2
$2.23M Buy
13,057
+1,242
+11% +$200K 0.42% 59
2023
Q1
$1.96M Buy
11,815
+1,686
+17% +$272K 0.41% 56
2022
Q4
$1.79M Buy
10,129
+165
+2% +$28.5K 0.41% 61
2022
Q3
$1.63M Buy
9,964
+233
+2% +$39.4K 0.42% 58
2022
Q2
$1.73M Buy
9,731
+64
+0.7% +$11.4K 0.43% 56
2022
Q1
$1.72M Buy
9,667
+769
+9% +$131K 0.38% 68
2021
Q4
$1.52M Buy
8,898
+544
+7% +$89.1K 0.35% 70
2021
Q3
$1.35M Buy
8,354
+149
+2% +$25.4K 0.32% 75
2021
Q2
$1.35M Sell
8,205
-491
-6% -$81.3K 0.34% 71
2021
Q1
$1.4M Sell
8,696
-13,349
-61% -$2.16M 0.37% 70
2020
Q4
$3.53M Buy
22,045
+104
+0.5% +$15.3K 0.81% 24
2020
Q3
$3.27M Buy
21,941
+2,593
+13% +$384K 0.88% 24
2020
Q2
$2.72M Sell
19,348
-29
-0.1% -$4.23K 0.81% 26
2020
Q1
$2.54M Buy
19,377
+346
+2% +$49.1K 0.99% 21
2019
Q4
$2.78M Sell
19,031
-79
-0.4% -$10.7K 0.96% 23
2019
Q3
$2.47M Sell
19,110
-2,887
-13% -$380K 0.92% 23
2019
Q2
$3.06M Buy
21,997
+2,211
+11% +$306K 1.12% 17
2019
Q1
$2.77M Buy
19,786
+203
+1% +$27.2K 1.02% 18
2018
Q4
$2.53M Buy
19,583
+2,789
+17% +$389K 1.01% 21
2018
Q3
$2.32M Sell
16,794
-1,293
-7% -$172K 0.84% 27
2018
Q2
$2.19M Sell
18,087
-2,700
-13% -$337K 0.77% 30
2018
Q1
$2.9M Buy
20,787
+25
+0.1% +$3.38K 1.21% 20
2017
Q4
$2.9M Sell
20,762
-1,635
-7% -$228K 1.08% 21
2017
Q3
$2.91M Sell
22,397
-991
-4% -$131K 1.09% 19
2017
Q2
$3.09M Sell
23,388
-895
-4% -$114K 1.22% 13
2017
Q1
$3.03M Sell
24,283
-28
-0.1% -$3.35K 1.14% 13
2016
Q4
$2.8M Sell
24,311
-48
-0.2% -$5.54K 1.18% 17
2016
Q3
$2.88M Buy
24,359
+2,891
+13% +$351K 1.19% 14
2016
Q2
$1.83M Sell
21,468
-2,842
-12% -$323K 0.96% 22
2016
Q1
$2.63M Buy
24,310
+153
+0.6% +$15.8K 1.26% 16
2015
Q4
$2.52M Buy
24,157
+13,252
+122% +$1.33M 1.15% 16
2015
Q3
$1.02M Buy
10,905
+1,832
+20% +$177K 0.76% 33
2015
Q2
$884K Sell
9,073
-2,570
-22% -$257K 0.63% 44
2015
Q1
$1.17M Buy
11,643
+1,961
+20% +$199K 0.81% 30
2014
Q4
$1.01M Buy
9,682
+2,239
+30% +$236K 0.74% 38
2014
Q3
$793K Sell
7,443
-856
-10% -$88.8K 0.63% 47
2014
Q2
$868K Sell
8,299
-1,310
-14% -$132K 0.67% 42
2014
Q1
$944K Buy
+9,609
New +$891K 0.79% 26

Other funds holding JNJ

Archford Capital Strategies's JNJ Position: Q2 2026 in Review

Archford Capital Strategies increased its Johnson & Johnson (JNJ) stake by 51% in Q2 2026, buying an estimated $3.18M and bringing the position to 40,636 shares worth $10.3M. The position accounts for 1.05% of the portfolio, ranked #22.

Archford Capital Strategies first reported a position in JNJ in Q1 2014 and has held it in 50 quarters since. 1,883 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Archford Capital Strategies held 40,636 shares of Johnson & Johnson worth $10.3M as of Q2 2026.
  • Archford Capital Strategies bought 13,660 Johnson & Johnson shares in Q2 2026, an estimated $3.18M.
  • Johnson & Johnson made up 1.05% of Archford Capital Strategies's portfolio in Q2 2026, its #22 holding.
  • Archford Capital Strategies first reported a position in Johnson & Johnson in Q1 2014 and has held it in 50 quarters since.
  • 1,883 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.